Skip to Navigation
Velindre NHS Trust
The Velindre NHS Trust incorporates Velindre Hospital in Cardiff.
This trust only has results for severe acute toxicity after chemotherapy (reported 2021-22 onwards).
Other results are not relevant for this trust because it is a tertiary referral centre providing chemotherapy.
All Patients: |
Trust
|
Network
|
National
|
Number of patients in Audit |
N/A |
2335 |
35779 |
Case ascertainment (%)
|
N/A |
Good |
Good |
|
Data completeness of:
|
|
|
|
– Pre-treatment TNM (%) |
N/A |
96 |
86 |
– Performance status (%) |
N/A |
98 |
89 |
Patients having major resection: |
Trust |
Network |
National |
Number of patients in Audit |
N/A |
1436 |
19631 |
ASA grade 1 (%) |
N/A |
6 |
9 |
ASA grade 2 (%) |
N/A |
49 |
53 |
ASA grade 3 (%) |
N/A |
37 |
31 |
ASA grade 4+ (%) |
N/A |
7 |
2 |
ASA grade not recorded (%) |
N/A |
1 |
4 |
|
Data completeness of: |
|
|
|
7 Audit items for risk-adjustment (%)
|
N/A |
95 |
87 |
Key:
-
- > 80%
-
- 50 - 80%
-
- < 50%
All Patients: |
Trust
|
Network
|
National
|
Number of patients in Audit |
N/A |
2335 |
35779 |
Seen by Clinical Nurse Specialist (%) |
N/A |
88 |
88 |
Patients having major resection: |
Trust
|
Network
|
National
|
Number of patients in Audit |
N/A |
1436 |
19614 |
Distant metastases (%) |
N/A |
8 |
5 |
Urgent or emergency surgery (%) |
N/A |
18 |
15 |
At least 12 lymph nodes excised (%)
|
N/A |
89 |
84 |
Laparoscopic surgery attempted (%) |
N/A |
65 |
72 |
Risk-adjusted length of stay > 5 days (%)
|
N/A |
60 |
55 |
Patients having major resection for stage III colon cancer: |
Trust
|
Network
|
National
|
Number of patients in audit
|
N/A |
N/A |
10747 |
Adjuvant chemotherapy (%)
|
N/A |
N/A |
62 |
Patients receiving chemotherapy after major resection for stage III colon cancer: |
Trust
|
Network
|
National
|
Number of patients in audit
|
114 |
N/A |
6608 |
Severe acute toxicity after adjuvant chemotherapy (%)
|
23 |
N/A |
22 |
Patients having major resection: |
Trust
|
Network
|
National
|
Number of patients in Audit |
N/A |
N/A |
4251 |
Neoadjuvant therapy (%)
|
N/A |
N/A |
33 |
Circumferential resection margin: Recorded (%) |
N/A |
91 |
89 |
Circumferential resection margin: Negative (%) |
N/A |
86 |
83 |
Rectal volume
|
N/A |
N/A |
4377 |
Patients in APER/Hartmanns estimate: |
Trust
|
Network
|
National
|
Number of patients in APER/Hartmanns estimate |
N/A |
1145 |
19644 |
APER/Hartmanns (%)
|
N/A |
45 |
37 |
Compare trust outcomes
Copyright © 2024 National Bowel Cancer Audit | Lovingly Crafted by
Mixd